All
ABCD Has Inspired Hope and Transformed Lives For 25 Years Through Its Customized Emotional Support for Anyone Impacted by Breast Cancer
In 1992, Milwaukee broadcast journalist Melodie Wilson Oldenburg announced on live television she had been diagnosed with breast cancer.
Surgery May Extend Survival For Patients with GIST and Liver Metastases
For patients with gastrointestinal stromal tumors with liver metastases, treatment with surgery and chemotherapy has been found to have survival benefits.
HT-001 Addresses Skin Toxicities in Patients With Cancer
In patients with cancer, HT-001, designed to address skin toxicities, elicited encouraging interim safety and efficacy results in the CLEER-001 trial
The Subcutaneous Approval of Opdivo Makes Waves in Future of Cancer Care
Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient access, according to experts.
Most Cures to Cancer Shared on TikTok Are Fake, Research Shows
Findings show that 81% of posts related to cancer on the social media platform TikTok touted fake cures.
Finding Strength Through Faith and Positivity During Cancer
I share how faith, positive affirmations and resilience helped me overcome stage 2 colon cancer and find strength in recovery.
Machine Learning Predicts Gleevec Nonadherence in Patients With GIST
Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others in patients with GIST.
Elinzanetant May Treat Hot Flashes Caused by Breast Cancer Treatment
Elinzanetant significantly reduced the frequency and severity of hot flashes in women with breast cancer who were undergoing hormone therapy.
FDA Grants Priority Review to Sunvozertinib for EGFR Exon20+ NSCLC
The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.
Expert Expands on Side Effects Related to ADC Treatment in Breast Cancer
Dr. Aditya Bardia shared his insights on what he believes are the top side effects to be aware of when undergoing ADC treatment for breast cancer.
The Waiting Room: An Underappreciated Experience
As a cancer treatment waiting room volunteer, I’ve discovered a unique community of shared experiences and unexpected connections.
The Pros and Cons of Seeking a Second Opinion In Cancer Treatment
An expert explains the importance of getting a second opinion during a cancer journey.
Fixed-Dose Subcutaneous Sarclisa Combo is Non-Inferior to IV Sarclisa in R/R Myeloma
Treatment with fixed-dose subcutaneous Sarclisa plus Pomalyst and dexamethasone was non-inferior to IV Sarclisa in relapsed/refractory multiple myeloma.
Sasanlimab Improves Event-Free Survival for Some With Bladder Cancer
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
Delving into Subcutaneous Versus Intravenous Opdivo in Solid Tumors
Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors.
Always Bring a Second Set of Ears to Your Oncology Checkup!
At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling overwhelmed and alone.
HIPEC May Not Improve Outcomes for Recurrent Epithelial Ovarian Cancer
Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.
SBRT May Be a Viable Option for Patients With Liver Cancer
CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.
The Gift of a Second Chance After My Stem Cell Transplant
After experiencing unexplained symptoms, I was diagnosed with multiple myeloma and underwent a stem cell transplant.
FDA Grants Fast Track Designation for Abenacianine in Lung Cancer Surgery
The FDA has granted fast track designation for abenacianine to help surgeons better visualize lung tumors during minimally invasive surgery.
A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval
Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.
The Impact of Yescarta on Long Term Quality of Life in R/R Follicular Lymphoma
Dr. Sattva S. Neelapu discusses how the CAR-T therapy Yescarta impacts the quality of life of patients with R/R indolent non-Hodgkin lymphoma.
P1101 Treatment Meets Phase 3 Primary End Point in Essential Thrombocythemia
P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the primary end goal of SURPASS-ET.
Learning to ‘Let it Be’ After Poor Test Results
When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort in listening to music.
Peter Yarrow Dies of Bladder Cancer, Dick Vitale Cleared for ESPN Return and More
From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, here is this week’s news.
First-Line Lenvima Plus Keytruda Misses Mark in Endometrial Cancer
For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve outcomes versus chemotherapy.
FDA Grants BTD to the ADC GSK’227 in Relapsed/Refractory Osteosarcoma
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with relapsed/refractory osteosarcoma.
Laparoscopic Wedge and Endoscopic Resection Are Safe, Feasible in Gastric GISTs
Both laparoscopic wedge and endoscopic resection are safe and feasible treatment approaches for patients with gastric gastrointestinal stromal tumors.
A New Year, A New Approach to Survivorship After Cancer
As I shift from an oncologist to a gynecologist for breast screenings, I examine both my reluctance to let go of the past and my hopes for the future.
Minoxidil May Safely Aid in Hair Growth for Patients With Breast Cancer
Low-dose oral minoxidil, the hair growth drug that is the active ingredient in Rogaine, may be safe and effective for patients with breast cancer.
